The study aimed to evaluate the prognostic significance of carcinoembryonic antigen levels in pleural lavage fluid ( p-CEA) in patients with completely resected non-small-cell lung cancer (NSCLC).
INTRODUCTION
Non-small-cell lung cancer (NSCLC) is the leading cause of cancer deaths in most countries, including Japan [1, 2] . Although complete resections can be achieved, the prognosis for NSCLC is sometimes poor, with recurrence rates of 35-50% [1] . Pleural lavage cytology (PLC) is the microscopic study of cells obtained after saline is instilled into, and retrieved from, the thoracic cavity in patients without preoperative pleural effusion during surgery for NSCLC. PLC is known as an independent prognostic factor for patients with NSCLC [3, 4] .
Carcinoembryonic antigen levels in serum (s-CEA) have been found to be correlated with disease stage and prognosis, and several reports have indicated a relationship between preoperative and postoperative s-CEA and the prognoses of patients with operable NSCLC [5, 6] . CEA can also be detected in pleural effusions as well as the serum in patients with lung cancer [7] . However, little is known regarding the significance of CEA levels in pleural lavage fluid ( p-CEA) in patients with resectable NSCLC. Therefore, we investigated the prognostic significance of p-CEA in patients with completely resected NSCLC.
the inclusion criteria that patients should have had surgeries with curative intent, without neoadjuvant chemotherapy or radiotherapy, had definitive histopathological diagnoses of NSCLC, complete resection with no residual carcinoma (R0 resection) and without severe adhesions between the lung and chest wall. All patients were staged according to the sixth edition of the TNM classification of malignant tumours [8] . The following information was extracted from the patient charts: age at surgery, sex, smoking history, tumour diameter, pleural invasion, lymph node status, stage, type of surgical procedure, PLC, histological subtype, s-CEA and p-CEA.
The clinical investigation section of our hospital measured s-CEA using a two-site immunoenzymometric assay. The normal upper limit for this assay was 5 ng/ml.
Immediately after thoracotomy, the pleural cavity was washed with 100 ml of physiological saline solution. The fluid was collected and immediately centrifuged for 5 min at 1500 rpm. p-CEA was measured using the same assay as for s-CEA. Obtained p-CEA was normalized to the total protein concentration determined using a protein assay kit and expressed as ng/g protein.
The remaining sediment of each fluid sample after centrifugation was used for cytological examinations. Cytological findings were graded into five classes (class I-V), of which classes IV and V were defined as cancer-cell positive.
Follow-up evaluations
All patients who underwent lung resection were followed up from the day of surgery. Postoperative follow-up procedures, including physical examination and chest roentgenogram every 3 months and chest computed tomography (CT) every 6 months, were performed for the first 2 years. Afterward, physical examination and chest roentgenogram were performed every 6 months and chest CT was performed every year. Recurrence was defined as any unequivocal occurrence of new cancer foci in a diseasefree patient. The site of the first cancer recurrence as well as the interval between surgery and cancer recurrence were determined. Disease-free survival (DFS) was calculated as the interval between the date of surgery and the date of the first confirmation of cancer recurrence, death without evidence of recurrence or the last clinical contact attesting to a disease-free status.
Statistical analysis
Results are presented as numbers (%) or medians, unless otherwise stated. Frequencies were compared using a χ 2 test for categorical variables and Fisher's exact test was used for small samples such as those with an expected value under 10. MannWhitney U-tests were used to compare continuous variables. Receiver operating characteristic (ROC) curves of p-CEA for recurrence prediction were generated to determine the cut-off value that yielded optimal sensitivity and specificity. The patient population was subdivided based upon the cut-off for p-CEA derived from the ROC curves. DFS and overall survival (OS) were evaluated using the Kaplan-Meier method. Differences in DFS or OS were assessed using a log-rank test. To assess the possible independent effects of p-CEA on DFS or OS, we conducted multivariate analysis using the Cox proportional hazards model using variables with P-values of <0.05 in univariate analysis. P < 0.05 was considered statistically significant. Statistical analysis was conducted using SPSS software (version 10.5, SPSS Inc., Chicago, IL, USA). Table 1 summarizes the characteristics of the 72 study patients. The mean follow-up period after surgery was 57.5 months, during which disease recurred in 25 patients (34.7%). Most of the first recurrent regions were distant metastasis (n = 22; 88.0%). There were a few local recurrences (n = 3; 12.0%; Table 2 ). Four patients (5.6%) had positive PLC findings.
RESULTS
Median s-CEA and p-CEA were 3.8 ng/ml and 65.2 ng/g protein, respectively. Linear regression analysis revealed a significant relationship between s-CEA and p-CEA (r = 0.271; R 2 = 0.0734; P = 0.022).
ROC curves identified an optimal p-CEA cut-off of 38 ng/g protein for predicting the recurrence of NSCLC [n = 72; area under the curve (AUC) = 0.669; 95% confidence interval (CI) = 0.541-0.796; sensitivity = 91.7%; specificity = 43.7%; P = 0.020]. However, no such indicator could be identified for s-CEA (AUC = 0.535; 95% CI = 0.392-0.678; P = 0.629; Fig. 1 ). At a cut-off of 38 ng/g protein, high p-CEA was significantly correlated with positive pleural invasion, high s-CEA and recurrence. However, high p-CEA was not correlated with positive PLC (Table 3) . Figure 2A shows significant differences in DFS between patients who had p-CEA ≤38 ng/g protein (5-year DFS = 86.5%) and >38 ng/g protein (5-year DFS = 47.7%; P = 0.0013). Figure 2B shows significant differences in OS between patients who had p-CEA ≤38 ng/g protein (5-year OS = 90.5%) and >38 ng/g protein (5-year OS = 63.0%; P = 0.010). Even for Stage I NSCLC, the 5-year DFS was significantly different between patients with p-CEA ≤38 and >38 ng/g protein (88.2 vs 53.8%; P = 0.017; Fig. 2C ). No significant differences in DFS and OS were observed between patients with s-CEA ≤5.0 and >5.0 ng/ml (Fig. 3) .
Univariate analyses for DFS of the 72 patients included age, sex, smoking history, tumour size, pleural invasion, nodal involvement, PLC, histology, s-CEA and p-CEA (Table 4) . Larger tumours, positive pleural invasion, lymph node metastasis, histology (non-adenocarcinoma) and higher p-CEA were correlated with a shorter DFS. Finally, multivariate analysis that included tumour size, pleural invasion, nodal involvement, histology and p-CEA showed that p-CEA [hazard ratio (HR) = 4.38; 95% CI = 1.26-15.3; P = 0.021) was an independent prognostic factor for DFS (Table 4) . Univariate analyses for OS of the 72 patients included age, sex, smoking history, tumour size, pleural invasion, nodal involvement, PLC, histology, s-CEA and p-CEA (Table 5) . Lymph node metastasis, histology (non-adenocarcinoma) and higher p-CEA were correlated with a shorter OS. Finally, multivariate analysis that included nodal involvement, histology and p-CEA showed that p-CEA (HR = 6.34; 95% CI = 1.41-28.46; P = 0.016) was an independent prognostic factor for OS as well as nodal involvement and histology (Table 5 ).
DISCUSSION
The results of our study showed that high p-CEA was significantly correlated with high rates of pleural invasion and s-CEA. This may indicate that CEA production either by the primary tumour or by metastatic tumour cells present throughout the body could also have some influence on p-CEA via systemic circulation. In our study, most of the first recurrences were distant metastases and the number of patients with local recurrence was low. These findings support the hypothesis that high p-CEA indicates systemic disease as well as local spreading, such as pleural invasion.
Currently, little is known regarding p-CEA in NSCLC. A few reports have shown that p-CEA was a prognostic factor for patients with NSCLC or lung adenocarcinoma [9, 10] . One study reported that increased p-CEA was an independent prognostic determinant for patients with lung adenocarcinoma [9] . Another study reported that p-CEA was higher in NSCLC than in benign disease and that p-CEA was an independent predictor of NCSLC [10] . These studies showed the possibility of using p-CEA as a prognostic factor for NSCLC, and the results of our study support this.
However, the methods used to determine p-CEA in the abovementioned studies were different from that in our study. In the above studies, the pleural cavity was washed with 200 ml of physiological saline, and p-CEA was determined as ng/ml without normalization; therefore, the volume of physiological saline used could have influenced p-CEA. In contrast, we normalized our measured p-CEA with respect to the total protein concentration; thus, we expressed p-CEA as ng/g protein. This method has been used for CEA in peritoneal washes in gastric cancer, which can correct for interinstitutional differences in the volumes of saline used for peritoneal or pleural lavage [11] . One of the limitations of using pleural lavage fluid is that techniques differ from centre to centre. Although International PLC Collaborators recommended 100 ml of saline irrigated over the lung surface immediately after thoracotomy and before lung resection, the volume of saline used for pleural lavage sometimes differ among institutions [3] . However, our normalized p-CEA method can be adapted by other institutions at which various doses of saline are used for collecting pleural lavage fluid.
The present study demonstrated that the AUC of an ROC for p-CEA for predicting recurrence was greater than that for s-CEA. Moreover, significant differences were observed in DFS and OS between patients with high p-CEA and those with low p-CEA, while no significant differences were observed in DFS and OS between patients with high and low s-CEA. Furthermore, univariate and multivariate analyses demonstrated that p-CEA was an independent prognostic factor for DFS and OS, while s-CEA was not. These findings indicate that p-CEA may be a more sensitive marker for postoperative NSCLC prognosis than s-CEA. The measurement of s-CEA was standard in this study, and the small number of patients in our study might have influenced the results that s-CEA was not a significant predictor for NSCLC prognosis, although s-CEA has been recognized as a prognostic factor for resectable NSCLC [5, 6] . Regardless, p-CEA was shown to be prognostic factor for NSCLC in our study.
Our study showed that p-CEA was the strongest prognostic factor for DFS in patients with NSCLC, and nodal involvement was not an independent prognostic factor for DFS. In general, lymph node metastasis is a strong prognostic factor in patients with NSCLC. Most of the patients in this our study had Stage I disease, and the small number of node-positive patients may have affected the DFS results. However, lymph node metastasis was an independent factor for OS, which is the hardest endpoint, in this study. This is a reasonable result.
The limitations of our study include the small number of patients, especially those with advanced disease enrolling over a long period, and no data for other prognostic factors, such as preoperative maximum standardized uptake values on 18F-fluoro-2-deoxyglucose positron emission tomography of the primary tumour, lymphatic and vascular invasion of the tumour [12] [13] [14] . To validate the prognostic significance of p-CEA for resectable NSCLC, a large multicentre cohort study is now underway.
In conclusion, p-CEA has a higher predictive value for NSCLC recurrence than s-CEA and is an independent prognostic factor for patients with resectable NSCLC. Normalized p-CEA values can be applied to multiple institutions in which different volumes of saline may be used for obtaining pleural lavage fluid.
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